PPP2R5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.768000E-01
Normal-vs-Stage2
9.507000E-01
Normal-vs-Stage3
3.401200E-01
Normal-vs-Stage4
5.099200E-01
Stage1-vs-Stage2
5.727200E-01
Stage1-vs-Stage3
3.002400E-01
Stage1-vs-Stage4
7.527400E-01
Stage2-vs-Stage3
1.822230E-01
Stage2-vs-Stage4
2.964800E-01
Stage3-vs-Stage4
1.481840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.059200E-01
Normal-vs-AfricanAmerican
2.146400E-01
Normal-vs-Asian
6.478800E-01
Caucasian-vs-AfricanAmerican
5.860300E-02
Caucasian-vs-Asian
1.915780E-01
AfricanAmerican-vs-Asian
5.022600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.939200E-01
Normal-vs-Female
9.469400E-01
Male-vs-Female
7.879400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.570600E-01
Normal-vs-Age(41-60Yrs)
9.081400E-01
Normal-vs-Age(61-80Yrs)
9.357000E-01
Normal-vs-Age(81-100Yrs)
9.114600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.423000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.262600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.847600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.087400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.587400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.792800E-01
Normal-vs-Daily Drinker
7.443400E-01
Normal-vs-Weekly Drinker
8.913800E-01
Normal-vs-Occasional Drinker
8.272400E-01
Normal-vs-Social Drinker
6.701600E-01
Non Drinker-vs-Daily Drinker
4.911000E-01
Non Drinker-vs-Weekly Drinker
7.897600E-01
Non Drinker-vs-Occasional Drinker
5.992600E-01
Non Drinker-vs-Social Drinker
4.754600E-01
Daily Drinker-vs-Weekly Drinker
7.951600E-01
Daily Drinker-vs-Occasional Drinker
3.028200E-01
Daily Drinker-vs-Social Drinker
9.703800E-01
Weekly Drinker-vs-Occasional Drinker
5.501400E-01
Weekly Drinker-vs-Social Drinker
7.740600E-01
Occasional Drinker-vs-Social Drinker
2.872600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.581500E-02
Normal-vs-Grade 2
8.584000E-03
Normal-vs-Grade 3
2.203900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.549600E-01
Grade 1-vs-Grade 3
5.574400E-01
Grade 1-vs-Grade 4
3.581500E-02
Grade 2-vs-Grade 3
9.658200E-01
Grade 2-vs-Grade 4
8.584000E-03
Grade 3-vs-Grade 4
2.203900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.672200E-01
Normal-vs-NonDiabetic
9.906600E-01
Diabetic-vs-NonDiabetic
1.423030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.591200E-01
Normal-vs-NoPancreatitis
8.534800E-01
Pancreatitis-vs-NoPancreatitis
6.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.334200E-01
Normal-vs-N1
9.273200E-01
N0-vs-N1
2.594800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.045400E-01
Normal-vs-TP53-NonMutant
8.505600E-01
TP53-Mutant-vs-TP53-NonMutant
3.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
